fda and compounded glp 1 Compound versions of GLP-1 drugs for weight loss halted by Compounded GLP-1s: Why doctors worry
Description
Two experiments used the same amount of fructose, two experiments used 10 mg of aspartame, and four experiments used no allulose or no intake as a comparator
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
Bertilsson G, Patrone C, Zachrisson O, et al
They produce 15-21% body weight reduction over 72 weeks
